These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 15756712)
21. A novel cell compatible impingement system to study in vitro drug absorption from dry powder aerosol formulations. Bur M; Rothen-Rutishauser B; Huwer H; Lehr CM Eur J Pharm Biopharm; 2009 Jun; 72(2):350-7. PubMed ID: 18771729 [TBL] [Abstract][Full Text] [Related]
22. Sustained delivery by leucine-modified chitosan spray-dried respirable powders. Learoyd TP; Burrows JL; French E; Seville PC Int J Pharm; 2009 May; 372(1-2):97-104. PubMed ID: 19429272 [TBL] [Abstract][Full Text] [Related]
23. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine. Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683 [TBL] [Abstract][Full Text] [Related]
24. Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections. Matinkhoo S; Lynch KH; Dennis JJ; Finlay WH; Vehring R J Pharm Sci; 2011 Dec; 100(12):5197-205. PubMed ID: 22020816 [TBL] [Abstract][Full Text] [Related]
25. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying. Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478 [TBL] [Abstract][Full Text] [Related]
26. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers. Corrigan DO; Corrigan OI; Healy AM Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654 [TBL] [Abstract][Full Text] [Related]
27. Insulin-micro- and nanoparticles for pulmonary delivery. Klingler C; Müller BW; Steckel H Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621 [TBL] [Abstract][Full Text] [Related]
28. Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate. Alhusban FA; Seville PC J Microencapsul; 2009 Aug; 26(5):444-55. PubMed ID: 18855201 [TBL] [Abstract][Full Text] [Related]
29. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447 [TBL] [Abstract][Full Text] [Related]
30. Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations. Pilcer G; Vanderbist F; Amighi K Int J Pharm; 2008 Jun; 358(1-2):75-81. PubMed ID: 18359587 [TBL] [Abstract][Full Text] [Related]
31. Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid. Hansen T; Holm P; Schultz K Int J Pharm; 2004 Dec; 287(1-2):55-66. PubMed ID: 15541912 [TBL] [Abstract][Full Text] [Related]
32. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients. Minne A; Boireau H; Horta MJ; Vanbever R Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052 [TBL] [Abstract][Full Text] [Related]
33. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation. van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699 [TBL] [Abstract][Full Text] [Related]
34. Preparation of DNA dry powder for non-viral gene delivery by spray-freeze drying: effect of protective agents (polyethyleneimine and sugars) on the stability of DNA. Kuo JH; Hwang R J Pharm Pharmacol; 2004 Jan; 56(1):27-33. PubMed ID: 14979998 [TBL] [Abstract][Full Text] [Related]
35. Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid/cyclodextrin inclusion complexes. Cabral-Marques H; Almeida R Eur J Pharm Biopharm; 2009 Sep; 73(1):121-9. PubMed ID: 19446024 [TBL] [Abstract][Full Text] [Related]
36. Characterisation of salmon calcitonin in spray-dried powder for inhalation. Effect of chitosan. Yang M; Velaga S; Yamamoto H; Takeuchi H; Kawashima Y; Hovgaard L; van de Weert M; Frokjaer S Int J Pharm; 2007 Mar; 331(2):176-81. PubMed ID: 17126507 [TBL] [Abstract][Full Text] [Related]
37. Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing. Irngartinger M; Camuglia V; Damm M; Goede J; Frijlink HW Eur J Pharm Biopharm; 2004 Jul; 58(1):7-14. PubMed ID: 15207532 [TBL] [Abstract][Full Text] [Related]
38. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections. Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012 [TBL] [Abstract][Full Text] [Related]
39. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608 [TBL] [Abstract][Full Text] [Related]
40. Spray drying of an attenuated live Newcastle disease vaccine virus intended for respiratory mass vaccination of poultry. Corbanie EA; Remon JP; Van Reeth K; Landman WJ; van Eck JH; Vervaet C Vaccine; 2007 Nov; 25(49):8306-17. PubMed ID: 17977632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]